Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

2.1K

[Heart and liver fibrosis: the components of a single equation]

O M Drapkina, Iu S Drapkina

    Kardiologiia
    |February 24, 2015
    PubMed

    Insights

    Myocardial fibrosis, a key factor in heart disease, involves collagen buildup due to heart pressure overload. Blocking the renin-angiotensin-aldosterone system (RAAS) may prevent fibrosis in multiple organs.

    Area of Science:

    • Cardiovascular Pathophysiology
    • Fibrosis Research
    • Organ Damage Mechanisms

    Context:

    • Chronic pressure overload leads to cardiac hypertrophy and fibrosis.
    • Myocardial injury is frequently associated with liver damage.
    • The renin-angiotensin-aldosterone system (RAAS) links cardiac and hepatic fibrosis.

    Purpose:

    • To explore the role of RAAS activation in the pathogenesis of myocardial and liver fibrosis.
    • To highlight the therapeutic potential of RAAS-blocking drugs for fibrotic diseases.

    Summary:

    • Myocardial fibrosis, characterized by excessive collagen accumulation, results from chronic heart pressure overload and contributes to cardiac hypertrophy.
    • This process is interconnected with liver damage, with RAAS activation serving as a key link.
    • RAAS inhibitors offer a promising therapeutic strategy to interrupt this fibrotic cycle.

    Impact:

    • RAAS-blocking drugs may prevent fibrosis not only in the heart and liver but also in other organs.
    • Understanding the RAAS pathway provides a basis for novel antifibrotic therapies.
    • This research contributes to the broader understanding of fibrogenesis as a non-specific process.

    More Related Videos

    Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy10:10

    Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

    Published on: July 20, 2022

    4.9K
    3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis06:46

    3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

    Published on: February 25, 2022

    2.5K

    Related Concept Videos

    Liver Regeneration01:24

    Liver Regeneration

    The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
    Cells of Liver
    The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
    5.3K
    Liver Physiology01:30

    Liver Physiology

    The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
    Metabolic Regulation:
    The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
    4.5K
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    358
    Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

    Ultrasound II: Endoscopic Ultrasound and FibroScan

    Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
    Endoscopic Ultrasound (EUS):
    1.2K
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    263
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    4.8K